TY - JOUR
T1 - Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites
AU - Phipps, Kyle D.
AU - Surette, Alexi P.
AU - O'Connell, Paul A.
AU - Waisman, David M.
PY - 2011/11/1
Y1 - 2011/11/1
N2 - Macrophages are critical drivers of tumor growth, invasion, and metastasis. Movement of macrophages into tumors requires the activity of cell surface proteases such as plasmin. In this study, we offer genetic evidence that plasminogen receptor S100A10 is essential for recruitment of macrophages to the tumor site. Growth of murine Lewis lung carcinomas or T241 fibrosarcomas was dramatically reduced in S100A10- deficient mice compared with wild-type mice. The tumor growth deficit corresponded with a decrease in macrophage density that could be rescued by intraperitoneal injection of wild-type but not S100A10-deficient macrophages. Notably, macrophages of either genotype could rescue tumor growth if they were injected into the tumor itself, establishing that S100A10 was required specifically for the migratory capability needed for tumor homing. Conversely, selective depletion of macrophages from wild-type mice phenocopied the tumor growth deficit seen in S100A10-deficient mice. Together, our findings show that S100A10 is essential and sufficient for macrophage migration to tumor sites, and they define a novel rate-limiting step in tumor progression.
AB - Macrophages are critical drivers of tumor growth, invasion, and metastasis. Movement of macrophages into tumors requires the activity of cell surface proteases such as plasmin. In this study, we offer genetic evidence that plasminogen receptor S100A10 is essential for recruitment of macrophages to the tumor site. Growth of murine Lewis lung carcinomas or T241 fibrosarcomas was dramatically reduced in S100A10- deficient mice compared with wild-type mice. The tumor growth deficit corresponded with a decrease in macrophage density that could be rescued by intraperitoneal injection of wild-type but not S100A10-deficient macrophages. Notably, macrophages of either genotype could rescue tumor growth if they were injected into the tumor itself, establishing that S100A10 was required specifically for the migratory capability needed for tumor homing. Conversely, selective depletion of macrophages from wild-type mice phenocopied the tumor growth deficit seen in S100A10-deficient mice. Together, our findings show that S100A10 is essential and sufficient for macrophage migration to tumor sites, and they define a novel rate-limiting step in tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=80155192757&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80155192757&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-11-1748
DO - 10.1158/0008-5472.CAN-11-1748
M3 - Article
C2 - 22042827
AN - SCOPUS:80155192757
SN - 0008-5472
VL - 71
SP - 6676
EP - 6683
JO - Cancer Research
JF - Cancer Research
IS - 21
ER -